M4I Joins Waters Centers of Innovation Programjuly 7, 2016
At a ceremony and symposium at Maastricht University, Waters Corporation officially welcomed the Maastricht MultiModal Molecular Imaging Institute (M4I) into the Waters Centers of Innovation (COI) Program. Under the direction of Professor Ron Heeren, the institute conducts research into applications for mass spectrometry in three main areas: oncology, neurology and cardiovascular medicine.
“In 2014, we welcomed
“Prof. Heeren is a true visionary and we are extremely pleased to welcome him into our COI Program,” said
For its research, the Institute employs three forms of mass spectrometry – mass spectrometry imaging (MSI) coupled with ion mobility and high spectral mass resolution. The scope of Prof. Heeren’s use of imaging mass spectrometry is wide-ranging. He uses it to determine where molecules of all types – lipids, intact proteins, endogenous peptides, drug metabolites – are localized within a tissue sample - and which are found in high concentrations and which are not - all in an effort to improve the understanding of disease progression and regression.
In an interview published in 2014, Prof. Heeren said, “I dare to predict that in ten years’ time, this imaging technique will be a standard diagnostic tool and patients will be assessed on their individual molecular status. We’re already well on the way in oncology, neurology and cardiovascular medicine.”
Precision or personalized medicine is the development of treatments that are attuned to the specific biology of an individual patient. More specifically, by understanding the molecular heterogeneity of tumors and their different cellular phenotypes, precise treatments can be formulated that offer a patient the best chance of a long and healthy life.
To salute the work of Prof. Heeren and the